MDM2 and MDM4: p53 regulators as targets in anticancer therapy

1 juil. 2007The International Journal of Biochemistry & Cell Biology

DOI : 10.1016/j.biocel.2007.03.022

Auteurs

Franck Toledo, Geoffrey M. Wahl